| Cell line name | HeLa Tet-On | ||
|---|---|---|---|
| Synonyms | HeLa-Tet-On; HeLa-tet-on | ||
| Accession | CVCL_IY74 | ||
| Resource Identification Initiative | To cite this cell line use: HeLa Tet-On (RRID:CVCL_IY74) | ||
| Comments | Population: African American. Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16. Transfected with: UniProtKB; P04483; Escherichia coli Tn10 tetR. Transfected with: UniProtKB; P06492; Human herpesvirus 1 VP16 (UL28) (with p.Met1_Arg360del). Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Discontinued: Takara/Clontech; Catalog number 630901. Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. | ||
| Disease | Human papillomavirus-related cervical adenocarcinoma (NCIt: C27677) | ||
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||
| Hierarchy | Parent: CVCL_0030 (HeLa) Children:
| ||
| Sex of cell | Female | ||
| Age at sampling | 30Y6M | ||
| Category | Cancer cell line | ||
| Cross-references | |||
| Cell line databases/resources | TOKU-E; 3679 | ||
| Encyclopedic resources | Wikidata; Q54882680 | ||
| Entry history | |||
| Entry creation | 15-May-2017 | ||
| Last entry update | 30-Jan-2024 | ||
| Version number | 11 | ||